PS www.ProStocks.com
|
|
| IPO Open | Aug 7, 2017 |
| IPO Close | Aug 10, 2017 |
| IPO Price | ₹72 |
| Face Value | ₹10 |
| IPO Size | ₹14.23 Cr |
| Listing At | NSE SME |
| Lot Size | 1600 |
Feb 28, 2023 11:48:00 AM
Shares of Vaishali Pharma Ltd jumped nearly 3 percent in intraday trade on Tuesday after the company announced that it has received multiple supply orders from overseas clients worth $73.85 ...
Publish by : MSNMar 2, 2023 7:37:00 AM
Mumbai (Maharashtra) [India], March 1: Mumbai based Vaishali Pharma Ltd has received orders worth USD 73.85 million (Approx. Rs. 600 crore) from overseas buyer for purchase of Antibiotics ...
Publish by : The Free Press JournalMar 1, 2023 5:15:00 PM
Mumbai based Vaishali Pharma Limited, engaged in supply of pharmaceutical products to corporates, hospitals and retails stores in the domestic and overseas market has received orders worth Rs. 600 ...
Publish by : PharmabizFeb 28, 2023 2:34:00 PM
Vaishali Pharma has received multiple orders worth about Rs 600 crore ($74 million) from overseas buyers for the purchase of antibiotic pharmaceutical products. The order will be executed in six ...
Publish by : Business LineMay 12, 2020 7:36:00 PM
LTRN believes it can better stratify patient populations for improved trial results for previously failed Phase 3 trials drug candidates. LTRN believes it can better stratify patient populations ...
Publish by : TheStreet.comMar 11, 2023 8:07:00 PM
Sudarshan Pharma Industries Private Limited SME IPO comes with an issue size of 6,862,400 shares of ?10 worth ?50.10 Cr. The subscription for this SME IPO opened on 09 March 2023 and will last ...
Publish by : MintAug 7, 2020 3:27:00 AM
The scale of the IPO – which is the largest in the US this year across all industrial sectors – reflects Royalty Pharma’s position as the largest player in the niche area of pharmaceutical ...
Publish by : pharmaphorumFeb 1, 2023 4:29:00 PM
Royalty Pharma is planning the biggest IPO of the year as the market’s appetite for biotech stocks remains strong. The company said in a filing with the US financial regulator that it plans ...
Publish by : pharmaphorumApr 9, 2018 1:23:00 PM
View all information regarding the medicines that are manufactured by Vaishali Pharmaceuticals including its generic drug name, trade name, how to use, the price, and its composition. This ...
Publish by : MedindiaJan 19, 2021 6:35:00 PM
Who would have thought that a year with a recession caused by a pandemic would also have one of the strongest IPO markets in decades? But it did. Who would have thought that a year with a ...
Publish by : NasdaqOct 9, 2020 7:24:00 PM
InMed Pharmaceuticals (INM) has filed to raise $10 million from the sale of common stock and warrants in an uplisting / Nasdaq IPO, according to an amended registration statement. Vancouver ...
Publish by : TheStreet.comFeb 27, 2023 2:30:00 AM
Every last one of those companies had to start somewhere. They each sprang to trading life with initial public offerings (IPOs), turning from private companies to public ones, attracting investors ...
Publish by : InvestopediaVaishali Pharma IPO Listing Date
› Listing Date: Tuesday, August 22, 2017
› NSE Symbol: VAISHALI
› ISIN: INE972X01014
› Issue Price: Rs 72 Per Equity Share
› Face Value: Rs 10 Per Equity Share
The issue of Vaishali Pharma Ltd opens on Aug 07, 2017 and closes for subscription on Aug 10, 2017. The equity shares of the company to be list at NSE Emerge. The price band for the issue has been fixed at Rs 71 at lower level and Rs 72 at upper level.
Vaishali Pharma Ltd is entering in the capital market with an IPO of 1,976,000 Equity Shares of Rs 10. The price band for the issue has been fixed at Rs 71 at lower level and Rs 72 at upper level.
Vaishali Pharma Ltd is a pharmaceutical company engaged in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. They are operating both in domestic and export markets. They have also established office in the Vietnam. At present they are supplying in around 10 countries.
The issue opens on Aug 07, 2017 and closes for subscription on Aug 10, 2017. The equity shares of the company to be list at NSE Emerge.
The Vaishali Pharma IPO is proposed to open on Aug 7, 2017. The IPO application ends on Aug 10, 2017.
Retail investors can apply in the retail or non-institutional investor category from Aug 7, 2017 to Aug 10, 2017. The Vaishali Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Vaishali Pharma IPO will open for subscription on Aug 7, 2017. The public issue will close on Aug 10, 2017.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
DRHP
